ZimVie confirms it has finalized its acquisition by ARCHIMED.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 20 2025
0mins
Acquisition Completion: ARCHIMED has successfully completed its acquisition of ZimVie, as announced on July 20, 2025.
Stockholder Compensation: ZimVie stockholders will receive $19.00 in cash for each share of ZimVie common stock they own, following the completion of the transaction.
Stock Market Impact: As a result of the acquisition, ZimVie's common stock is no longer traded on the NASDAQ stock exchange.
Transaction Details: The acquisition involved ARCHIMED acquiring all outstanding shares of ZimVie stock.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
